SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-077637
Filing Date
2022-12-05
Accepted
2022-12-05 16:24:15
Documents
1
Period of Report
2022-12-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6427
  Complete submission text file 0001213900-22-077637.txt   8967
Mailing Address 3052 PACIFIC AVENUE SAN FRANCISCO CA 94115
Business Address
Tananbaum James B. (Reporting) CIK: 0001581754 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 221445255

Mailing Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET, SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund V, L.P. (Reporting) CIK: 0001792204 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 221445254

Mailing Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939
Business Address 900 LARKSPUR LANDING CIRCLE, SUITE 150 LARKSPUR CA 94939 415-877-4887
Foresite Capital Management V, LLC (Reporting) CIK: 0001792206 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40067 | Film No.: 221445256

Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations